x
The Role of Resveratrol in Achieving Optimal Health P-4
Take note that the some of the studies on resveratrol's effects on diseases usually employ high doses of resveratrol – higher than most supplements. For example, the largest U.S. clinical trial on resveratrol, which involved 119 Alzheimer's patients, made use of doses as high as 1 gram per day – this is typically higher than most supplements, which are only around 250 to 500 milligrams per dose. Ideally, consult a physician if you want to take resveratrol for its therapeutic effects, as you may need proper guidance if you want to take higher doses. Nevertheless, even just regular supplementation and getting it from food sources may already offer profound impacts on your well-being.
Resveratrol is generally safe, and according to WebMD, there are no severe side effects associated with this supplement, even in high doses. However, please note that resveratrol is recommended for adults ages 18 years old and older. Do not give this supplement to children, as well as pregnant or breastfeeding women, without the advice of a health practitioner. Resveratrol may also interact with medications like blood thinners and NSAIDs, so refrain from taking this supplement if you're using these prescription drugs.
Article Produced By
Dr. Mercola
Posted by
Chuck Reynolds
The reasoning for this article is to supply you information about this wonderful product and also for me to find at least two or more people for this simply Amazing Opportunity.. You just need to follow the 4 simple steps.. (Join,Train,sigup 2 or more people and then you duplicate. It's that simple..). This business can make you money in the thousands or just be a customer for a very satisfying experience.
View this video as it helps you to understand a very simple Business Plan. Check it out, then
View these videos (4 of them, very short (total less then 5 min)) that explains how simple
this business works and if so inclined, click on my name above, call me or just sign up
either as a Customer or Distributor.
